课题基金 / 基金详情

Novel Keap1-Nrf2 Inhibitors as Chemopreventive Agents

Novel Keap1-Nrf2 Inhibitors as Chemopreventive Agents
作为化学预防剂的新型 Keap1-Nrf2 抑制剂
批准号:
7455941
负责人:
LONGQIN HU
金额:
$7.73万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2010-06-30

项目摘要

项目成果

LONGQIN HU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Research over the last decade has demonstrated that Keap1-Nrf2-antioxidant response element (ARE) system plays a key role in cancer chemoprevention by many chemicals like sulforaphane, curcumin, and epigallo- catechol gallate derived from natural sources such as fruits, vegetables, and tea products. Modification, by these natural electrophiles such as isothiocyanates and Michael acceptors, of sensitive cysteine residues found in the redox "sensor" protein Keap1 is believed to be responsible for causing the dissociation of Keap1- Nrf2 complex and subsequent upregulation of oxidative stress response enzymes. To address concerns over the general use of purified natural thiol-reactive compounds as chemopreventive agents, novel short peptides and small organic molecules are designed and screened specifically for the inhibition of Keap1-Nrf2 interaction. These inhibitors will mimic the actions of reactive oxygen species and electrophiles like isothiocyanates and Michael acceptors in the induction of cytoprotective enzymes but will potentially be more selective and specific. Two structure-based approaches are proposed here to start from the recently available 3-D X-ray cocrystal structure of Keap1 Kelch domain with Nrf2 peptide to discover novel selective Keap1-Nrf2 inhibitors: a) to design conformationally restricted cyclic peptides to mimic the ¿-hairpin loop of Nrf2 that interacts with Keap1 and b) to use in silico screening of virtual libraries for small molecules that could bind to Keap1 with high affinity and thus prevent the binding of Nrf2. These studies will provide important information about, and novel small molecule inhibitors of, the protein-protein interaction between Keap1 and Nrf2, and facilitate the development of more potent and selective Keap1-Nrf2 inhibitors as inducers of oxidative stress response enzymes.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.apsb.2015.05.008
发表时间: 2015-07
期刊: Acta pharmaceutica Sinica. B
影响因子: --
作者: [Abed DA, Goldstein M, Albanyan H, Jin H, Hu L]
通讯作者: Hu L
DOI: 10.1002/med.21257
发表时间: 2012-07
期刊: MEDICINAL RESEARCH REVIEWS
影响因子: 13.3
作者: [Magesh, Sadagopan, Chen, Yu, Hu, Longqin]
通讯作者: Hu, Longqin
DOI: 10.1016/j.bmcl.2013.12.072
发表时间: 2014-02-01
期刊: Bioorganic & medicinal chemistry letters
影响因子: 2.7
作者: [Chen L, Magesh S, Wang H, Yang CS, Kong AN, Hu L]
通讯作者: Hu L
L-Cystine Diamides as Inhibitors of L-Cystine Stone Formation in Cystinuria
  • 批准号:
    10083210
  • 项目类别:
  • 资助金额:
    $52.23万
  • 财政年份:
    2017
  • 负责人:
    LONGQIN HU
  • 依托单位:
HTS fluorescence polarization assay for inhibitors of Keap1-Nrf2 interaction
  • 批准号:
    8070110
  • 项目类别:
  • 资助金额:
    $4.64万
  • 财政年份:
    2010
  • 负责人:
    LONGQIN HU
  • 依托单位:
HTS fluorescence polarization assay for inhibitors of Keap1-Nrf2 interaction
  • 批准号:
    8204553
  • 项目类别:
  • 资助金额:
    $3.86万
  • 财政年份:
    2010
  • 负责人:
    LONGQIN HU
  • 依托单位:
Optimization of EphA subtype-selective antagonists as probes for the nervous syst
  • 批准号:
    7936819
  • 项目类别:
  • 资助金额:
    $25.01万
  • 财政年份:
    2009
  • 负责人:
    LONGQIN HU
  • 依托单位:
海外基金